More Deaths From Amylin And Eli Lilly's Byetta

The Food and Drug Administration reported two more deaths of patients taking Amylin Pharmaceuticals Inc.s' (Nasdaq: AMLN) and Eli Lilly & Co.'s (NYSE: LLY) diabetes drug Byetta. Four additional patients developed pancreatitis. Shares of Amylin plunged $4.45 to close at $29.76 while Eli Lilly stock slipped 73 cents to close at $48.05.